Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout
Clinical trial NCT02330796 · COMPLETED
Trial details
- NCT number
- NCT02330796
- Sponsor
- Revive Therapeutics, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-11-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.